Isabella Graef, MD | oneAMYLOIDOSISvoice

Published: Sep 13, 2019

Tags

Isabella Graef is an Assistant Professor of pathology at the Stanford University Medical Center. She received her medical degree and training in dermatology and immunology from the University of Vienna, Austria. She came to the US as a Fulbright fellow to complete training (M.S.) in immunology at the University of California, Berkeley.

Dr. Graef founded Eidos Therapeutics together with Dr. Mamoun Alhamadsheh in 2013 and has served as a member of their board of directors since April 2016.

Representative Publications:

AG10 Inhibits Amyloidogenesis and Cellular Toxicity of the Familial Amyloid Cardiomyopathy-Associated V122I Transthyretin

Design of B-Amyloid Aggregation Inhibitors From a Predicted Structural Motif

Potent Kinetic Stabilizers That Prevent Transthyretin-Mediated Cardiomyocyte Proteotoxicity

Calcineurin/NFAT Signaling is Required for Neuregulin-Regulated Schwann Cell Differentiation

Role of Transcription Factor NFAT in Glucose and Insulin Homeostasis

First Name

Isabella

Last Name

Graef

Address

Department of Pathology<br>
The Stanford University Medical Center<br>
Edwards R204B<br>
300 Pasteur Drive